|
|
||||||||
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
The initial steps that determine development of memory in CD4 cells are unknown. To distinguish an intrinsic capacity of effectors to become memory cells from contributions of as yet undefined survival factors, we analyzed the effects of withdrawal of signals via TCR, costimulation, and cytokines from Th1 or Th2 primary effectors induced in vitro from TCR-transgenic CD4 cells. Withdrawal of stimulation caused the transition of effectors to resting populations with a memory phenotype that did not undergo division following transfer to normal syngeneic recipients. The return of effectors to rest was accompanied by acquisition of the capacity to function as memory cells in vivo as defined by extended persistence and a more rapid response to Ag in vivo than naive cells in adoptive hosts. Upon challenge with Ag, these in vitro-rested Th1 and Th2 cells were similar to long-term in vivo-rested memory cells, but distinct from in vitro-generated primary effectors and in vivo-restimulated memory effectors by their ability to resist apoptosis. Cessation of stimulation may occur when activated CD4 cells exit lymphoid tissues after priming and transition to memory may be initiated if effectors either fail to gain access to Ag in peripheral tissues where restimulation can lead to activation-induced cell death or do not receive sufficient stimuli to continue a response. Our results suggest that the first stage leading to stable CD4 memory could occur stochastically and independently of instructional processes and as such, the development of memory may be a default pathway when signals that direct responses are not received.
This article has been cited by other articles:
![]() |
N. Pakpour, C. Zaph, and P. Scott The Central Memory CD4+ T Cell Population Generated during Leishmania major Infection Requires IL-12 to Produce IFN-{gamma} J. Immunol., June 15, 2008; 180(12): 8299 - 8305. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Thirumalapura, H. L. Stevenson, D. H. Walker, and N. Ismail Protective Heterologous Immunity against Fatal Ehrlichiosis and Lack of Protection following Homologous Challenge Infect. Immun., May 1, 2008; 76(5): 1920 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bell, J. S. Ellis, F. B. Guloglu, D. M. Tartar, H.-H. Lee, R. D. Divekar, R. Jain, P. Yu, C. M. Hoeman, and H. Zaghouani Early Effector T Cells Producing Significant IFN-{gamma} Develop into Memory J. Immunol., January 1, 2008; 180(1): 179 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. McKinstry, S. Golech, W.-H. Lee, G. Huston, N.-P. Weng, and S. L. Swain Rapid default transition of CD4 T cell effectors to functional memory cells J. Exp. Med., September 3, 2007; 204(9): 2199 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zaunders, W. B. Dyer, M. L. Munier, S. Ip, J. Liu, E. Amyes, W. Rawlinson, R. De Rose, S. J. Kent, J. S. Sullivan, et al. CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells. J. Virol., October 1, 2006; 80(20): 10151 - 10161. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gray, S. L. Reiner, D. F. Smith, P. M. Kaye, and P. Scott Antigen-Experienced T Cells Limit the Priming of Naive T Cells during Infection with Leishmania major J. Immunol., July 15, 2006; 177(2): 925 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zaph, K. A. Rook, M. Goldschmidt, M. Mohrs, P. Scott, and D. Artis Persistence and Function of Central and Effector Memory CD4+ T Cells following Infection with a Gastrointestinal Helminth J. Immunol., July 1, 2006; 177(1): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Weber, J. Harbertson, E. Godebu, G. A. Mros, R. C. Padrick, B. D. Carson, S. F. Ziegler, and L. M. Bradley Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol., April 15, 2006; 176(8): 4730 - 4739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection Blood, September 1, 2005; 106(5): 1660 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Parameswaran, R. Suresh, V. Bal, S. Rath, and A. George Lack of ICAM-1 on APCs during T Cell Priming Leads to Poor Generation of Central Memory Cells J. Immunol., August 15, 2005; 175(4): 2201 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. van Rijt, S. Jung, A. KleinJan, N. Vos, M. Willart, C. Duez, H. C. Hoogsteden, and B. N. Lambrecht In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma J. Exp. Med., March 21, 2005; 201(6): 981 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Harari, F. Vallelian, P. R. Meylan, and G. Pantaleo Functional Heterogeneity of Memory CD4 T Cell Responses in Different Conditions of Antigen Exposure and Persistence J. Immunol., January 15, 2005; 174(2): 1037 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Zand, B. J. Briggs, A. Bose, and T. Vo Discrete Event Modeling of CD4+ Memory T Cell Generation J. Immunol., September 15, 2004; 173(6): 3763 - 3772. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kondrack, J. Harbertson, J. T. Tan, M. E. McBreen, C. D. Surh, and L. M. Bradley Interleukin 7 Regulates the Survival and Generation of Memory CD4 Cells J. Exp. Med., December 15, 2003; 198(12): 1797 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Huston, and S. L. Swain IL-7 Promotes the Transition of CD4 Effectors to Persistent Memory Cells J. Exp. Med., December 15, 2003; 198(12): 1807 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Salek-Ardakani, J. Song, B. S. Halteman, A. G.-H. Jember, H. Akiba, H. Yagita, and M. Croft OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation J. Exp. Med., July 21, 2003; 198(2): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |